Abiomed Inc (NASDAQ:ABMD)

During the Trading Day
69.03 -1.49 / -2.11%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
69.03 0.00 / 0.00%
 
Volume: 16.2K
MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook
4:38pm / Zacks.com
Morning Market Gainers
Mar 24 / Benzinga
Can The Uptrend Continue for ABIOMED (ABMD)? - Tale of the Tape
9:12am / Zacks.com
New Lifetime High Reached: Abiomed (ABMD)
Mar 24 / TheStreet.com
Allscripts and Drexel University Extend EHR Alliance - Analyst Blog
Mar 25 / Zacks.com
Stocks Climb, Nasdaq Leads Markets as Health Care Rebounds
Mar 24 / TheStreet.com
Abiomed Attains New 52-Week High on Impella 2.5 Approval - Analyst Blog
Mar 25 / Zacks.com
ERBA Diagnostics (ERB) Rises: Stock Adds 5.3% in Session - Tale of the Tape
Mar 20 / Zacks.com
Today's Perilous Reversal Stock: Abiomed (ABMD)
Mar 25 / TheStreet.com
Varian Opens New Unit in Algeria, Consolidates in North Africa - Analyst Blog
Mar 19 / Zacks.com
ABIOMED (ABMD) in Focus: Stock Surges 18% in Session - Tale of the Tape
Mar 25 / Zacks.com
Edwards Lifesciences Up on Positive PARTNER Trial Data - Analyst Blog
Mar 18 / Zacks.com
Notable 52-Week Highs and Lows 3/24: (ABMD) (MKC) (FRSH) High; (SONS) (CRK) Lower
Mar 24 / Investing Channel
CryoLife, CR Bard War over Patent Infringement Continues - Analyst Blog
Mar 13 / Zacks.com
Why Abiomed, Inc. is Soaring Higher Today
Mar 24 / MotleyFool.com
Cantel Medical Beats Q2 Earnings, Provides Positive Outlook - Analyst Blog
Mar 13 / Zacks.com
Abiomed's Impella 2.5 FDA-Approved for PCI Procedures - Analyst Blog
Mar 24 / Zacks.com
Intersect ENT, Inc. (XENT) in Focus: Stock Jumps 5.1% - Tale of the Tape
Mar 13 / Zacks.com
Streetinsider.com's Hot Lunchtime Reads 3/24: (WLL) (YUM) (MTL) (ABMD)
Mar 24 / Investing Channel
ICON Launches Medical Device, Diagnostics Research Group - Analyst Blog
Mar 12 / Zacks.com
Health Services Stocks On The Rise With Help From 3 Stocks
Mar 24 / TheStreet.com
Merit Medical Posts Impressive Q4, Issues View for 3 Fiscals - Analyst Blog
Mar 12 / Zacks.com
Stocks Trade in Choppy Session as Dollar and Data Weigh on Wall Street
Mar 24 / TheStreet.com
Inogen (INGN) Postpones Q4 Results; Reiterates 2015 View - Analyst Blog
Mar 12 / Zacks.com
Benzinga's Volume Movers
Mar 24 / Benzinga
Varian Medical's ProBeam Proton Therapy Now in England - Analyst Blog
Mar 12 / Zacks.com
Stocks Hitting 52-Week Highs
Mar 24 / Benzinga
Inogen (INGN) Looks Good: Stock Adds 10.1% in Session - Tale of the Tape
Mar 12 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account